US spent nearly $32B in public funds on mRNA vaccine development, study finds
The US government contributed at least $31.9 billion in public funding to the development of mRNA-based Covid-19 vaccines, according to a new BMJ study.
That includes at least $337 million in the three decades prior to the pandemic, seven researchers from Brigham and Women’s Program On Regulation, Therapeutics, And Law (PORTAL) wrote. More than $29 billion was used to purchase vaccines.
For co-author and primary care physician Hussain Lalani, the study began as a way to understand the origins of mRNA vaccines and convey to patients that the Covid shots were not created overnight.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.